It appears that Medtronic continues to run afoul with the FDA. They received this FDA warning letter in Jan. 2022. Medtronic was late issuing a recall on the MiniMed insulin pump after the FDA had received more than 57,000 medical device reports (MAUDE) over the previous three years.
Recent Comments